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Background: Although donor age-related effects of characteristics of mesenchymal stem cells (MSC), such as a
decrease in the proliferation and differentiation capacity and an increase of senescence and apoptosis, are evident,
such effects are generally less prominent in adipose-derived stem cells (ASC). Using a hormone and growth factor
rich medium (KFSM), this study cultured ASC from abdominal subcutaneous fat of 27 adult females in three age
groups: 30-39 y, 40-49 y and 50-60 y, and investigated the growth and differentiation characteristics.
Results: The derived ASC had an immunophenotype similar to that of bone marrow derived MSC (BMSC). They
could be stably expanded with an average population doubling time of 21.5 ± 2.3 h. Other than a higher
pre-adipogenic commitment and a lower adipogenic differentiation capability in ASC derived from the old age
group, other characteristics including proliferation rate, doubling time, telomere length, as well as the osteogenic
and chondrogenic differentiation capacity were the same regardless of the donor’s age.
Conclusions: The study demonstrates a promising proliferation and differentiation capabilities of ASC regardless of
the donor’s age. The compromised adipogenic potential in the older donors could be a benefit for their application
in regeneration therapy.
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Aging is a complex process characterized by a variety of
disorders associated with generalized decline and incapa-
bility to maintain tissue homeostasis. Aging tissues typic-
ally demonstrate increased preponderance for degenerative
disorders and decreased repair capacity [1]. Stem cells in
numerous tissues replace mature cell loss during physical
activity or injury throughout life. The role of stem cells in
aging as well as age related decline in function of stem
cells are hotly debated issues [2,3].
Nowadays, increasing evidence supports the hypothesis
that cellular senescence recapitulates aspects of organism
aging and contributes to aging phenotypes in vivo [4,5], in* Correspondence: hidrchu@gmail.com
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reproduction in any medium, provided the orpart by limiting self-renewal of tissues by progenitor cells
[6,7]. The senescent phenotype is characterized by features
such as enlarged cell size, flattened morphology, and en-
hanced senescence-associated (SA)-β-galactosidase activ-
ity. Of the same concern is the senescence potential of
mesenchymal stem cells (MSC) derived from old donor.
MSC has widely being implicated as source for cell ther-
apy in regenerative medicine. For clinical application of
MSC, a long term proliferation capacity without senes-
cence is important and requires a long telomere. Telo-
meres protect chromosome ends from wasting by repeated
cell division [8] and are regarded as the mitotic clock of
the cell replication capacity [9,10].
MSCs have been characterized in tissues including
bone marrow, adipose, skeletal muscle, dermis and umbil-
ical cord [11] with similar morphological and immuno-
phenotypical characteristics [12]. Adult tissue-derivedd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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have attracted a lot of attention in cell therapy. However,
usage of BMSC may be restricted by donor age-dependent
decline of capability of proliferation [14-16]. Besides, the
osteogenic potential of BMSC has been reported to be
compromised with the advanced age of donor [17,18].
An alternative source MSC is adipose-derived stem
cells (ASC), which are thought to have advantages over
BMSC for the high abundance of source and ease of iso-
lation, expansion and cryopreservation [19]. The effect
of donor’s age on the proliferation and differentiation of
ASC is largely controversial (Table 1). There are claims
that old age of donor does not seem to affect the viability
of ASC [20,21] but other reports showed a compromised
viability [3,22,23]. While most reports showed a lower cap-
acity of adipogenic differentiation for old age donor
[3,21,22,24] but one report showed no difference [23]. As
to osteogenic differentiation, there were reports of lower
[3,24], higher [23] and no different [20] capacity in ASC
from old donor.
We assume a medium of low calcium and low serum
with hormone and antioxidant supplements such as the
keratinocyte serum free medium (KSFM) may overcome
the donor-age effect of ASC, thus explain the controversy
of previous studies. A comprehensive characterization of
the growth and differentiation properties as well as senes-
cence and telomere length were done in KSFM-cultured
ASC from donors of different ages. The results showed a
comparable growth and non-adipogenic differentiation
capacities in ASC regardless of the donor’s age.
Methods
Source of adipose tissue, patient age groups, and body
mass index
Twenty-seven female donors who underwent gyneco-
logical surgery were enrolled. The subjects were classified
into three age groups: 30–39 y (n = 10), 40–49 y (n = 10)






Van Harmelen et al.
2004 [22]
29 17-61 DMEM/F12 + 10%FCS ↓
de Girolamo et al.
2009 [24]
26 21-68 DMEM + 10%FBS
Zhu et al. 2009 [23] 26 20-58 DMEM + 10%FBS →
Alt et al. 2012 [3] 40 15-71 α-MEM + 20% FBS ↓
Chen et al. 2012 [20] 22 36-71 KFSM + NAC + 5% FBS →
Present study 27 30-60 KFSM + NAC + 5% FBS →
NAC N-acetyl cysteine.
KFSM keratinocyte serum free medium.
FBS fetal bovine serum.
FCS fetal calf serum.and 51.8 ± 3.6 y, respectively. The body mass index (BMI)
was calculated as body weight (kg)/height (m2). The mean
BMI in each group was 26.1 ± 5.3, 25.4 ± 4.8 and 25.3 ±
2.5 kg/m2, respectively. The Research and Ethics Commit-
tee of Buddhist Tzu Chi General Hospital approved this
study, and informed consent was obtained from each sub-
ject prior to tissue collection.
Derivation of ASC
Human adipose tissue was harvested from subcutaneous
fat (1 cm3) from the abdominal wall during gynecologic
surgery. Tissue samples were placed in Ca2+/Mg2+-free
phosphate-buffered saline solution (PBS), and then
transferred to the laboratory immediately. Human adi-
pose tissue was removed from the transport medium,
placed in a Petri dish, and cut into small pieces (1–
2 mm3) in the presence of Ca2+/Mg2+-free PBS. Tissues
were dissociated with 0.1 mg collagenase Ia (Sigma, St.
Louis, MO, USA) and incubated for 60 min at 37°C. Fol-
lowing enzymatic digestion, the resulting cells were col-
lected and cultured in keratinocyte-serum-free medium
(KSFM) (added epidermal growth factor and bovine pi-
tuitary extract, Gibco, 17005-042, USA) with 5% fetal
bovine serum (FBS), N-acetyl cysteine (NAC), L-ascorbic
acid-2-phosphate. Supernatant and debris were removed
from the culture dish on day 2 of culturing. The resulting
ASC culture was denoted as passage 0. To prevent spon-
taneous differentiation, cultures were maintained at sub-
confluent levels (<80% confluency). We usually passaged
cells at a ratio of 1:3. Passaging of ASC cultures was
performed using 2.5% trypsin/0.23 mM ethylenediamine-
tetraacetic acid (EDTA). Passaged cultures were defined as
passage 1.
Flow cytometry of ASC
Surface molecules of ASC cultures of passage 3 were
characterized by flow cytometry. Cells were detached









fat and omental fat
↓ ↓ Abdominal subcutaneous fat
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(Sigma, USA), and incubated with their respective anti-
body conjugated with fluorescein isothiocyanate (FITC)
or phycoerythrin (PE), including clustering of differenti-
ation (CD)13, CD34, CD44, CD45, CD56, CD90 and hu-
man leukocyte antigen (HLA)-ABC (BD, PharMingen,
Franklin Lakes, NJ, USA). Cells were analyzed using a
flow cytometer (Becton Dickinson, San Jose, CA, USA).
Proliferation assay and estimation of population
doubling time
The ASC were seeded in triplicate at a density of 2 × 103
cells/cm2, in a 96-well plate with KSFM with 5% FBS.
ASC at passage 2-3 were used for proliferation assay.
Cells were harvested and counted using a cell prolifera-
tion kit (XTT based, Biological Industries Ltd., Kibbustz
Beit Haemek, Israel) on days 0, 2, 3 and 4, and a growth
curve was generated. XTT solutions and PMS (N-methyl
dibenzopyrazine methyl sulfate) were defrosted immedi-
ately prior to use in a 37°C bath. PMS was added to the
XTT solution immediately before use. 50 μl of XTT/
PMS was added to each 100 μl culture. After 2-5 h of
incubation at 37°C, the optical density (OD) of the wells
was determined using a spectrophotometer (ELISA reader)
at a wavelength of 450 nm and a reference wavelength of
650 nm. To calculate the population DT, 1 × 104 cells were
seeded in a 10-cm Petri dish. The KSFM was changed
on day 4 and cells were harvested and counted on day 7.
The DT was calculated according to the formula: DT =
log (final cell number)-log (initial cell number) = K ×T,
where K is the generation constant (0.008963) and T is
time in hours [25].
Adipogenesis and measurement
Passage 2-3 of ASC were seeded in a 12-well plate at a
density of 5 × 104 with adipogenic medium Dulbecco’s
Modified Eagle Medium (DMEM) supplemented with
10% FBS, 1 μmol/L dexamethasone, 5 μg/mL insulin,
0.5 mmol/L isobutylmethylxanthine and 60 μmol/L
indomethacin). These ASC were allowed to grow for
14 days. The medium was changed every 3 days, after
which, the ASC were stained with Oil Red O. After
staining, the samples were washed twice with PBS. The
lipids were then extracted from the cells by 100% isopro-
panol and gentle shaking for 5 min. The concentration
of the lipids was measured based on the absorbance at
510 nm. The lipid quantity for each sample was mea-
sured in triplicate.
Osteogenesis and measurement
The passage 2-3 of ASC were seeded in a 12-well plate
at a density of 1 × 104 and grown with osteogenic me-
dium (DMEM supplemented with 10% FBS, 0.1 μmol/L
dexamethasone, 10 mmol/L β-glycerol phosphate, and50 μmol/L ascorbate) that was changed every 3 days. Cells
were allowed to grow for 21 days and stained with Alizarin
Red. For quantification of staining, 800 uL 10% (v/v) acetic
acid was added to each well, and the plate was incubated
at room temperature for 30 min with shaking. The mono-
layer, now loosely attached to the plate, was then scraped
from the plate with a cell scraper (Fisher Scientific,
Hampton, NH, USA) and transferred with 10% (v/v)
acetic acid to a 1.5-mL microcentrifuge tube with a
wide-mouth pipette. After vortexing for 30 s, the slurry
was overlaid with 500 uL of mineral oil (Sigma-Aldrich),
heated to exactly 85°C for 10 min, and transferred to ice
for 5 min. The slurry was then centrifuged at 20,000 g
for 15 min, and 500 uL of the supernatant was removed
to a new 1.5-mL microcentrifuge tube. Then 200 uL of
10% (v/v) ammonium hydroxide was added to neutralize
the acid. Aliquots (150 uL) of the supernatant were read
in triplicate at 405 nm in a 96-well format using opaque-
walled, transparent-bottomed plates (Fisher Scientific,
Hampton, NH, USA).
Chondrogenesis and measurement
The passage 2-3 of ASC were seeded in a 12-well plate at
number of 1 × 105 cells and were grown in chondrogenic
media consisting of DMEM, 10% FBS, 10 ng/ml TGF-β1,
50 μg/ml of ascorbic acid-2-phospate and 6.25 μg/ml of
insulin, and media were changed every three days. Cells
were incubated with the chondrogenic media at 37°C with
5% CO2 for three weeks. After fixing in paraformaldehyde,
cells were mounted on slides and stained using standard
Alcian Blue protocols. The cells also processed for
processed gene expression analysis via quantitative reverse
transcription polymerase chain reaction (qRT-PCR) for
cartilage specific matrix gene expression at Day 0 and Day
21. For quantification of incorporation of Alcian blue into
the proteoglycan-rich extracellular matrix, cultures were
incubated with 6 M guanidine hydrochloride overnight,
and subjected to photometric measurement at optical
density (OD) 595 nm [26]. For chondrogenesis in pellet
culture, a total of 5 × 105 cells were spun in 15 ml sterile
conical polypropylene tubes (Enzymax LLC, Kentucky,
USA) at 1000 rpm for five minutes to form spherical cell
pellets. The final volume of chondrogenic media was
250 μl per pellet. Medium change was performed three
times a week. The pellets were cultured for three weeks to
allow appreciable matrix accumulation. Thereafter, the
pellets were measured their sizes using ImageJ software
(free software developed by NIH).
RNA isolation and reverse transcription-polymerase chain
reaction (RT-PCR)
Total RNA was extracted using RNEasy® (Qiagen, USA)
according to the manufacturer’s instructions. Reverse
transcription-polymerase chain reaction (RT-PCR) with
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[27]. Briefly, total RNA was collected using TRIzol
(Invitrogen, Carlsbad, CA, USA), and complementary
DNA was synthesized using a SuperScript first-strand
synthesis system (Invitrogen, Carlsbad, CA, USA). Comple-
mentary DNA was amplified by PCR using the AmpliTaq
Gold Kit (Applied Biosystems, Foster City, CA, USA). The
PCR products were resolved on 2% agarose gels.
Real-time quantitative RT-PCR (qRT-PCR)
Real time quantitative RT-PCR was performed using
TaqMan Gene Expression assays and Applied Biosystems
(ABI) Step One Plus (Applied Biosystems, USA). Primer se-
quences for the adipogenesis gene, peroxisome proliferator-
activated receptor (PPAR-γ), were 5′-AGC CTC ATG
AAG AGC CTT CCA-3′, 5′- TCC GGA AGA AAC CCT
TGC A-3′; for the osteogenesis genes, osteopontin were 5′-
AGG AGG AGG CAG AGC ACA-3′, 5′- CTG GTATGG
CAC AGG TGA TG-3′; for the chondrogenisis genes, col-
lagen type 2A1 (COL2A1) and aggrecan (ACAN) were: 5'-
CAA CAC TGC CAA CGT CCA GAT-3', 5'-TCT TGC
AGT GGT AGG TGA TGT TCT-3'; and 5'-ACA GCT
GGG GAC ATT AGT GG-3', 5'-GTG GAA TGC AGA
GGT GGT TT-3', respectively; and for the internal control,
glyceraldehyde 3-phosphate dehydrogenase (GAPDH), were
5′- GGC AGC AGC AAG CAT TCC T-3′, 5′- GCC CAA
CAC CCC CAG TCA-3′. The PCR conditions were as fol-
lows: initial incubation at 50°C for 2 min and denaturation
at 95°C for 10 min, followed by 40 cycles of 95°C for 15 sec
and 60°C for 1 min.
Analysis of SA β-Gal activity
Senescence-associated β-galactosidase (SA-β-Gal) is a
commonly used marker for cell senescence [28,29]. For
SA-β-Gal stain, the ASC were washed with PBS, fixed
for 3-5 min (at room temperature) in 1% paraformalde-
hyde, washed and incubated at 37°C (no CO2) with fresh
β-Gal stain solution (Cell Signaling Technology, Beverly,
MA, USA). Semiquantitative measurement of SA β-Gal
staining was performed by calculating the number of β-
Gal positive cells in three low power fields (100×) and
expressed as a percentage of all counted cells.
Measurement of telomere length by real time qPCR
ASC at passage 4 were used for telomere length assay.
Real-time qPCR assay of telomere length [30] was
followed with minor modifications. Two real time PCRs
were performed, one to determine the cycle threshold
(Ct) value for telomere amplification, and the other to
determine the Ct value for amplification of a single-copy
control gene RPLP0 (acidic ribosomal protein P0), with
primer sequences and PCR conditions described in [30].
All real-time qPCRs were carried out using the ABI Step
One Plus Sequence Detection System (Applied Biosystems).Intra- and inter-assay reproducibility of both telomere and
RPL0 PCR results were evaluated initially in a series of ex-
periments using dilutions. The standard deviation (% of
coefficient of variation) of Ct values in 3 replicates of sam-
ples amplified in the same PCR run for telomere and
RPL0 were ≤ 0.16 (≤0.73%) and ≤0.22 (≤0.50%), respect-
ively. Both reference DNA and DNA samples were ana-
lyzed in duplicate. Mean Ct values were used to calculate
relative telomere length using the telomere to sample
(T/S) ratio derived from the following formula: ΔCtsample =
ΔCttelomere − Ctcontrol, ΔΔCt =ΔCtsample − ΔCtreference curve
(where ΔCtreference curve = Cttelomere − Ctcontrol) and then T/
S = 2−ΔΔCt .
Statistics
GraphPad Prism version 5.00 for Windows was used in
this study. Mean levels of differentiation (adipogenesis
and osteogenesis) and gene expression (PPAR-γ and
osteopontin) across three donor age groups were com-
pared using one way ANOVA and post-hoc tests (the
Bonferroni multiple comparison test). The level of sig-
nificance was set at 0.05.
Results
ASC has an immunophenotype similar to BMSC
The derived ASC at passage 2 to 3 had a fibroblast-like
appearance resembling that of BMSC [31]. These ASC
in initial cultures were homogeneous in appearance and
could reach 80-90% confluence by 14 days. This morph-
ology was maintained up to passage 22. Flow cytometry
revealed surface expressions of CD13, CD44, CD90 and
HLA-ABC (typical MSC markers), while white blood cell
and NK cell markers CD45 and CD56 were not ex-
pressed (Figure 1). This pattern is consistent with that of
BMSC [31]. Meanwhile, CD34 was expressed in 11.9 ±
8.8%, 9.8 ± 7.7% and 16 ± 4% of ASC derived from 30-39 y,
40-49 y and 50-60 y age groups, respectively (P = 0.59,
ANOVA test). Previous report has revealed CD34 + cells
can be found in the ASC [32].
Proliferation rate and doubling time of ASC were not
compromised in older donor and low BMI
Growth curves of the first passage of ASC cultures of dif-
ferent donor age groups are outlined in Figure 2. The aver-
age population doubling time (DT) for all ASC donors
was 21.5 ± 2.3 h. No significant difference in growth kinet-
ics (Figure 2) and DT (Figure 3A) existed among the three
age groups. There was also no significant correlation of
BMI of the donor and population DT of derived ASC
(Figure 3B).
Lower adipogenic potential of ASC in the old age groups
Adipogenesis and lipid vacuole formation in the ASC were
studied by staining cells with Oil Red O. At day 14 post






























































































Figure 1 Immunophenotyping of ASC derived from donors of three age groups. Histograms of cell surface markers are demonstrated in
ASC derived from three age groups (n = 3 in each group) at passage 3. The respective isotype controls are showed as a shaded histograms. ASC
from the three age groups were all positive for CD13, CD34, CD44, CD90 and HLA-ABC, and negative for CD45 and CD56.
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positive lipid droplets within their cytoplasm (Figure 4A).
The amount of both intracellular lipid and the expression
of PPAR-γ gene were lower in the 40-49 y and ≥50 y age
groups than in the 30-39 y group (P for both markers
were <0.01 and <0.05, respectively) (Figure 4B and 4C).
Osteogenic potential of ASC was not related to donor’s age
Previously, a decline of osteogenic potential of ASC
derived from old donors was reported [14]. We per-
formed a detail characterization of osteogenesis of ASC.
Osteogenesis in ASC was stained with Alizarin Red to
determine calcium deposition. The cellular morphology
changed from spindle shape to cuboid shape. Low level ofosteogenesis were characterized by formation of a mono-
layer of Alizarin Red–positive cells, while higher staining
levels were characterized by the presence of strongly
stained multi-layered Alizarin Red–positive nodular struc-
tures with well-defined inter-nodular regions not con-
taining cells (Figure 5A). Osteogenic levels as measured
by quantified Alizarin Red staining and expression of
Osteopontin were not different among the three age groups
(Figure 5B and 5C).
Chondrogenic potential was not related to donor’s age
Upon induction of chondrogenic differentiation, ASC
conglobulated to micromass (Figure 6C). The sizes of the
microsphere as well as the levels of Alcian blue staining of
Figure 2 Growth kinetics of ASC derived from the three age
groups. Growth kinetics, as indicated as mean ± SD of the OD read
of cell density, of the three age groups are showed. The case
number of the 30-39 y, 40-49 y and over 50 y groups was 10, 10 and
7, respectively. * P < 0.05.
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chondrogenic genes, COL2A1 and ACAN, were not differ-
ent among the three age groups (Figure 6B-6E).
Senescence and telomere length of ASC
Senescent ASC express SA β-Gal to form a local blue pre-
cipitate (Figure 7A). There was a significant increase in
the numbers of SA β-Gal-positive cells in the ASC cul-
tured in late passage (P22) than the early passage (P13)
(Figure 7B); but the proportion of senescent cells in the
ASC culture did not differ among different age groups in
the same passage (Figure 7B). As shown in Figure 7C,
there was no significant difference in the telomere length
of ASC derived from the three age groups at passage of 4.
Discussion
The result of this study revealed that donor’s age does not
affect the capability of osteogenesis and chondrogenesis of
ASC, but the capability of adipogenenic differentiation is(A)
Figure 3 The population doubling time of ASC in relation to age and
age groups (n = 7, 9 and 5 in the 30-39 y, 40-49 y and 50-60 y groups, respsignificantly compromised in the old age donors. There
were significant lower levels of PPARγ mRNA and Oil Red
staining upon induction of adipogenic differentiation.
PPARγ is regarded as an adipogenic transcription factor.
Decrease of PPARγ could contribute to the age-related de-
clines in fat cell size and the capacity to store lipid as well
as insulin responsiveness [33]. PPARγ is lower in pre-
adipocyte cultured from older than younger human fol-
lowing exposure to differentiation medium [21,34]. PPARγ
is also reduced in fat tissue from various species in old age,
including rats and primates [34,35]. In aged mice, an al-
tered metabolism and volume of adipose tissue depots was
observed. The weight of the brown, epididymal, inguinal,
and retroperitoneal adipose depots were reduced by ad-
vanced age when total body weight was not changed [36].
There have been several reports of donor age effect on
the characteristics of ASC. As summarized in Table 1, a
wide range of variations of results of proliferation, osteo-
genesis and adipogenesis in relation to donor’s age was
noted in these studies. The wide discrepancy can be due
to differences of the gender of donor, range of age strati-
fication, sources of the adipose tissue and culture condi-
tions. There has been a report showing ASC derived
from women are less capable of osteoblastic differenti-
ation than ASC from men [37]. The age-related differ-
ence of osteogenesis can thus be less obvious in this
study of women than others of both sexes. Subjects in
the present study have an age range of 30 to 60 years.
The result of lower adipogenesis of ASC derived from
old age group is consistent with two previous studies
with a wider range of age (15-71 years and 21-68 years)
[3,24]. But we did not see the compromised osteogeneis
in old age group as compared to the very young age
group in these two previous reports.
We assume the use of different culture medium may
be the main reason of difference. The present study used
KSFM for culture of ASC. This is in contrast to the(B)
BMI of donors. The doubling times of cultured ASC from the three





























Figure 4 Compromised of adipogenic differentiation capability in ASC derived from old donors. (A) Different levels of Oil Red O staining
after induction of adipogenic differentionesis were demonstrated. Scale bar = 100 μm. (B) Mean mRNA levels of PPAR-γ are compared in different
donor’s age groups (n = 3 in each group). Levels are expressed as mean ± SD. Pre: pre-induction. Post: post-induction. (C) Quantification of Oil
Red O expression of ASC in the three groups (n = 3 in each group). *P < 0.05, ** P < 0.01.
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http://www.jbiomedsci.com/content/20/1/59alpha-MEM [3], DMEM [23,38], or DMEM/F12 [22] used
in other studies. These media contain a relative higher cal-
cium concentration. High calcium content (DMEM)
(1.8 mM) has been reported to adversely influence the
growth and proliferation potentials of adipogenic cellHigh Moderate
(A)
(B)
Figure 5 No difference of osteogenic differentiation in ASC derived fr
including Alizarin Red staining (A), Osteopontin mRNA (B) and quantificatio
age groups (n = 3 in each group). Levels are expressed as mean ± SD. Pre:[19,25,39]. KSFM medium is an optimized MCDB-153
medium with a low calcium content (0.09 mM). Supple-
mentation with hormones (bovine pituitary extract),
growth factors (rEGF) and anti-oxidants (NAC and ascor-
bic acid) can enhance the proliferation efficiency andLow No
(C)
Alizarin Red
om different age groups. Parameters of osteogenic differentiation














Figure 6 No difference of chondrogenic differentiation in ASC derived from different age groups. Parameters of chondrogenic
differentiation including Alcian blue staining (A), quantification of Alcian blue at OD 595 nm (B), micromass formation (C), size of micromass
(D) and COL2A1 (Collagen type 2A1) and ACAN (Aggrecan) mRNA level (E) were compared in ASC derived from the three age groups (n = 3 each).
Levels are expressed as mean ± SD.
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this medium [20] showed the same results of no differ-
ences of proliferation capability in ASC derived from
young (36.4 ± 11.8 years) and old (71.4 ± 3.6 years) donors
(Table 1). Thus, the growth potentials of ASC derived from
old donor could be maintained by culturing with low cal-
cium and nutrient enriched medium such as KSFM.
In this study, around 10 ~ 16% of ASC were positive
for CD34 surface marker. CD34 is often expressed on
hematopoietic stem cells. Findings of CD34 expression
in ASC have been inconsistent [40] and may relate to
the duration of cell culture, since a progressive down-
regulation of CD34 marker has been observed in ASC
culture [41,42]. Loss of CD34 expression may be related
to the physiological process of commitment and/or dif-
ferentiation from an immature status to more differenti-
ated ones such as the adipose, bone, or smooth muscle[32]. Conversely, the expression of CD34 may represent
a preadipocyte commitment of ASC [40]. In this study,
although there was no statistically significant difference
of CD34 percentage among different age groups (P = 0.59),
a seemly higher percentage of CD34 was found in ASC
derived from the older age group (16.1% vs. 9.8% and
11.9%). ASC derived from older women may have a higher
proportion of preadipocyte commitment and a lower cap-
ability of adipogenic differentiation.
Telomere shortening and resulted cell senescence and
growth arrest can be the major hurdle of cellular therapy
since it limits the expansion of MSC. It has also been
concerned that the cell division clock may approach
terminus in MSC from elderly donors. Using KFSM
medium, this study revealed no difference of telomere
length in ASC derived from the three age groups. This is




Figure 7 No difference of senescence-associated β-Gal activity and telomere length in ASC derived from different age groups.
Representative pictures (A) and the quantitative measurement (B) of senescence-associated (SA) β-Gal staining in ASC derived from three age
groups (n = 5 each) at two different passages are showed. *P < 0.05. (C) Relative lengths of telomere, as expressed as telomere/single-copy-gene
(T/S) ratios, are showed (n = 10 each in 30-39 y and 40-49 y groups, n = 7 in 50-60 y group).
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age of the donor [43].
For MSC of limited source such as bone marrow, ex-
tensive cell expansion may be needed for clinical use
and may encounter cell senescence after long passage.
As seen in this study, ASC is of no exception. A signifi-
cantly higher SA-β-gal activity was found in late pas-
sages. In this regard, adipose tissue can be acquired in
large amount to derive enough number of MSC for use
without extensive expansion.
Previous studies have revealed an increase of cell doub-
ling time with increased activity of SA-β-gal in BMSC
derived from old donors [16]. Compared to BMSC, ASC
has a generally lower activity of SA-β-gal, suggesting a less
aging activity [16]. Although there was a significant
correlation between the final population doubling number
and the age of donors [42], we found an equivalent cell
doubling time as well as SA-β-gal activity in ASC derived
from different donor age groups at earlier passages up to
p22. This amount of expansion is expected to generate
enough ASC for most regenerative uses.
Conclusions
In summary, this study demonstrates a promising prolif-
eration and longevity capacity of ASC regardless of the
age of the donor. Other than less adipogenesis, ASCfrom elder donors maintain the capability of osteogenic
and chondrogenic differentiation and longevity. The au-
tologous ASC from the elderly may become a promising
therapeutic agent especially for tissue repair and the
lower capacity of adipogenesis may be a benefit in this
utilization since adipose tissue is generally not required
for regeneration.
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